Swipe to discover more

• bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

  bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of BIOFIRE® SPOTFIRE® for pharmaceutical industries, where this innovative molecular testing system is designed to transform quality control. Building on the proven success of the BIOFIRE® FILMARRAY® platform, already adopted by leading global pharmaceutical companies, BIOFIRE® SPOTFIRE® introduces a simple, small and smart approach to mycoplasma detection, helping biopharmaceutical manufacturers strengthen quality control, accelerate decision-making, and protect patients.

  Read the press release
  

• Lab Professionals Celebrating Lab Professionals: A Look Behind the bioMérieux Bench

  Behind every diagnosis is a lab professional who made it possible, yet their expertise and dedication rarely get the recognition they deserve. And with the ever-evolving healthcare landscape, just trying to keep up can feel like a challenge.  

  Read the blog post
  

• Predicting Sepsis-Related Shock Earlier: How AI Could Transform Critical Care

  In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.

  Read the news